The Coca-Cola Amatil Ltd share price just hit a 52-week high: Too late to buy?

Yesterday the Coca-Cola Amatil Ltd (ASX:CCL) share price hit a 52-week high. Is it too late to invest in the beverage company?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Thanks to a 2% jump yesterday the Coca-Cola Amatil Ltd (ASX: CCL) share price hit a 52-week high of $10.83.

Despite its struggles, this gain means that the beverage company's shares have now climbed an astonishing 26% in the last 12 months.

Why have its shares rallied?

Coca-Cola Amatil's shares were given a boost last month after the release of a stronger-than-expected full-year result.

Although the company posted a 37% drop in net profit after tax to $246 million, this was largely the result of a $171.8 million after tax non-cash impairment charge taken on its SPC Ardmona business.

Excluding that charge the company posted a 6.2% increase in its underlying net profit after tax to $418 million. For a mature company like Coca-Cola Amatil I believe this underlying result should be regarded as a strong one.

Furthermore, the company has committed to buy back up to $350 million worth of its shares, representing approximately 4.6% of its float.

Is it too late to invest?

Whilst I have been a big fan of the company in the past, I don't think I would be a buyer at today's price.

Based on its underlying result I estimate its shares to be changing hands at approximately 20x earnings.

Although its shares do offer defensive qualities, I still think this is quite a premium for a company targeting mid-single digit earnings per share growth in FY 2017.

Because of this I would suggest investors hold off an investment and wait for a pull-back in order to pick up shares at a fairer price.

In the meantime an investment in consumer staples peers a2 Milk Company Ltd (Australia) (ASX: A2M) and Tassal Group Limited (ASX: TGR) could be a better option.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »